(Toronto, June 27, 2024) JMIR Publications announced today that JMIR Public Health and Surveillance has received a Journal Impact Factor (JIF) of 3.5 as published in the 2024 Journal Citation Report (JCR) from Clarivate. This follows our recent announcement that, according to Scopus CiteScore, JMIR Public Health and Surveillance is a Q1 journal in the “Public, Environmental & Occupational Health” and “Health Informatics” categories.
Here’s a selection of some of the highly cited articles from JMIR Public Health and Surveillance:
- COVID-19 Vaccine Hesitancy on Social Media: Building a Public Twitter Data Set of Antivaccine Content, Vaccine Misinformation, and Conspiracies
- COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey
- Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study
Overall, 8 JMIR Publications journals (more than half of our portfolio of journals with a JIF) secured positions in the top quartile of their respective categories.
A Complete List of JMIR Publications Titles With a JIF in 2024:
For 25 years, JMIR Publications has been advocating for open access in digital health. Discover our complete open access journal portfolio and explore the communities progressing digital health and health research in the internet age.
We are grateful to the scholars, researchers, institutions, funders, peer reviewers, editors, and editorial board members who have contributed to our mission of advancing scientific knowledge.
Submit your paper now to JMIR Public Health and Surveillance.